praziquantel has been researched along with HIV Coinfection in 36 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate trends in the efficacy of praziquantel (PZQ) suggestive of the emergence of drug resistance against Schistosoma mansoni infection after 12." | 7.75 | Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. ( Black, CL; Colley, DG; Evan Secor, W; Karanja, DM; Mwinzi, PN; Steinauer, ML, 2009) |
| "To investigate the effect of helminth infections and their treatment during pregnancy on HIV load, we conducted a 2 × 2 factorial randomized controlled trial of albendazole versus placebo and praziquantel versus placebo in pregnant women in Entebbe, Uganda." | 5.16 | The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda. ( Elliott, AM; Kaleebu, P; Kizito, D; Kyosiimire-Lugemwa, J; Lule, S; Muhangi, L; Muwanga, M; Nkurunziza, P; Webb, EL, 2012) |
| " We investigated systemic inflammation as measured by plasma levels of soluble tumor necrosis factor-alpha receptor II (sTNF-rII), interleukin-8, (IL-8), and IL-10 during schistosomiasis and HIV co-infection and after schistosomiasis treatment." | 5.13 | Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis. ( Butterworth, AE; Deelder, AM; Erikstrup, C; Gerstoft, J; Gomo, E; Kallestrup, P; Ostrowski, SR; Pedersen, BK; Ullum, H; van Dam, GJ; Zinyama-Gutsire, RB, 2008) |
| "To determine whether treatment of schistosomiasis has an effect on the course of human immunodeficiency virus type 1 (HIV-1) infection, individuals with schistosomiasis and with or without HIV-1 infection were randomized to receive praziquantel treatment at inclusion or after a delay of 3 months; 287 participants were included in the study, and 227 (79%) were followed up." | 5.11 | Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. ( Butterworth, AE; Erikstrup, C; Gerstoft, J; Gomo, E; Kallestrup, P; Mudenge, B; Ullum, H; van Dam, GJ; Zinyama, R, 2005) |
| "We showed that for a variation of efficacy between 30-70% of mass praziquantel administration for reducing the enhanced risk of HIV transmission per sexual act due to FGS, annual administration of praziquantel to school-age children in Zimbabwe could result in net savings of US$16-101 million compared with no mass treatment of schistosomiasis over a ten-year period." | 3.79 | Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. ( Atkins, KE; Galvani, AP; Meyers, LA; Ndeffo Mbah, ML; Orenstein, EW; Poolman, EM; Townsend, JP, 2013) |
| "To investigate trends in the efficacy of praziquantel (PZQ) suggestive of the emergence of drug resistance against Schistosoma mansoni infection after 12." | 3.75 | Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. ( Black, CL; Colley, DG; Evan Secor, W; Karanja, DM; Mwinzi, PN; Steinauer, ML, 2009) |
| "There is evidence from experimental models that the praziquantel-induced clearance of schistosomiasis is dependent on the host's immune response." | 3.73 | Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. ( Butterworth, AE; Erikstrup, C; Gerstoft, J; Gomo, E; Kallestrup, P; Ullum, H; van Dam, GJ; Zinyama, R, 2006) |
| "A prospective cohort study was conducted in two villages in Zambia to compare the efficacy of praziquantel in the treatment of schistosomiasis haematobium in people with and without concomitant infection with human immunodeficiency virus (HIV)." | 3.72 | Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. ( Ernest, A; Mwanakasale, V; Sukwa, TY; Tanner, M; Vounatsou, P; Ziba, M, 2003) |
| "Severe schistosomal myelopathy can provoke a complete flaccid paraplegia with areflexia, sphincter dysfunction and sensory disturbances." | 2.44 | Neurological complications of Schistosoma infection. ( Carod-Artal, FJ, 2008) |
| "Schistosomiasis is a curable parasitic infection that, if left untreated, can persist for 30 years even though the parasite cannot reproduce in its human host." | 2.38 | Schistosomiasis. ( Lucey, DR; Maguire, JH, 1993) |
| "Schistosomiasis is a highly prevalent parasitic infection causing significant morbidity and mortality in sub-Saharan Africa." | 1.35 | Seroprevalence of schistosomiasis in African patients infected with HIV. ( Fox, R; Seaton, RA; Smith, C; Smith, H, 2008) |
| "The effect of coinfection on HIV disease progression varied with species." | 1.32 | Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. ( Brown, M; Elliott, AM; Hughes, P; Kizza, M; Quigley, MA; Rowland, S; Watera, C; Whitworth, JA, 2004) |
| "To determine whether drug treatment of Schistosomiasis mansoni infection leads to a reduction in plasma HIV-1 RNA concentration in coinfected individuals." | 1.31 | The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. ( Andove, J; Colley, DG; Folks, TM; Karanja, DM; Lawn, SD; Mwinzia, P; Secor, WE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.56) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 16 (44.44) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kangogo, G | 1 |
| Conserve, DF | 1 |
| Kayuni, S | 1 |
| Kumwenda, MK | 1 |
| Dovel, KL | 1 |
| Chirombo, J | 1 |
| MacPherson, P | 1 |
| Corbett, EL | 1 |
| Butterworth, A | 1 |
| Choko, AT | 1 |
| Nalwoga, A | 1 |
| Webb, EL | 3 |
| Chihota, B | 1 |
| Miley, W | 1 |
| Walusimbi, B | 1 |
| Nassuuna, J | 1 |
| Sanya, RE | 1 |
| Nkurunungi, G | 1 |
| Labo, N | 1 |
| Elliott, AM | 6 |
| Cose, S | 1 |
| Whitby, D | 1 |
| Newton, R | 1 |
| Hotez, PJ | 3 |
| Engels, D | 3 |
| Gyapong, M | 2 |
| Ducker, C | 3 |
| Malecela, MN | 2 |
| Bustinduy, AL | 2 |
| Secor, WE | 5 |
| Harrison, W | 2 |
| Theobald, S | 1 |
| Thomson, R | 1 |
| Gamba, V | 1 |
| Masong, MC | 1 |
| Lammie, P | 1 |
| Govender, K | 1 |
| Mbabazi, PS | 1 |
| Livingston, M | 1 |
| Pillay, P | 1 |
| Zulu, SG | 1 |
| Sandvik, L | 1 |
| Kvalsvig, JD | 1 |
| Gagai, S | 1 |
| Galappaththi-Arachchige, HN | 1 |
| Kleppa, E | 1 |
| Ndhlovu, P | 1 |
| Vennervald, B | 2 |
| Gundersen, SG | 1 |
| Taylor, M | 1 |
| Kjetland, EF | 3 |
| Means, AR | 1 |
| van Lieshout, L | 2 |
| Brienen, E | 1 |
| Yuhas, K | 1 |
| Hughes, JP | 1 |
| Ndungu, P | 1 |
| Singa, B | 2 |
| Walson, JL | 1 |
| Fenwick, A | 1 |
| Sabina Mbabazi, P | 1 |
| Floerecke Kjetland, E | 1 |
| Yegorov, S | 1 |
| Joag, V | 1 |
| Galiwango, RM | 1 |
| Good, SV | 1 |
| Mpendo, J | 1 |
| Tannich, E | 1 |
| Boggild, AK | 1 |
| Kiwanuka, N | 1 |
| Bagaya, BS | 1 |
| Kaul, R | 1 |
| Muok, EM | 1 |
| Simiyu, EW | 1 |
| Ochola, EA | 1 |
| Ng'ang'a, ZW | 1 |
| Karanja, DM | 5 |
| Mwinzi, PN | 3 |
| Ndeffo Mbah, ML | 2 |
| Poolman, EM | 1 |
| Atkins, KE | 1 |
| Orenstein, EW | 1 |
| Meyers, LA | 1 |
| Townsend, JP | 1 |
| Galvani, AP | 2 |
| Downs, JA | 1 |
| Kabangila, R | 1 |
| Verweij, JJ | 1 |
| Jaka, H | 1 |
| Peck, RN | 1 |
| Kalluvya, SE | 1 |
| Changalucha, JM | 1 |
| Johnson, WD | 1 |
| Fitzgerald, DW | 1 |
| Chachage, M | 1 |
| Podola, L | 1 |
| Clowes, P | 1 |
| Nsojo, A | 1 |
| Bauer, A | 1 |
| Mgaya, O | 1 |
| Kowour, D | 1 |
| Froeschl, G | 1 |
| Maboko, L | 1 |
| Hoelscher, M | 1 |
| Saathoff, E | 1 |
| Geldmacher, C | 1 |
| Gilbert, JA | 1 |
| Stecher, CW | 1 |
| Kallestrup, P | 5 |
| Petersen, E | 1 |
| Pérez-Chacón, G | 1 |
| Pocaterra, LA | 1 |
| Rojas, E | 1 |
| Hernán, A | 1 |
| Jiménez, JC | 1 |
| Núñez, L | 1 |
| Gholam, P | 1 |
| Autschbach, F | 1 |
| Hartschuh, W | 1 |
| Erikstrup, C | 4 |
| Zinyama-Gutsire, RB | 1 |
| Gomo, E | 4 |
| van Dam, GJ | 3 |
| Deelder, AM | 1 |
| Butterworth, AE | 4 |
| Pedersen, BK | 1 |
| Ostrowski, SR | 1 |
| Gerstoft, J | 3 |
| Ullum, H | 4 |
| Black, CL | 1 |
| Steinauer, ML | 1 |
| Evan Secor, W | 1 |
| Colley, DG | 4 |
| Zinyama-Gutsire, R | 1 |
| Munyati, S | 1 |
| Mduluza, T | 1 |
| Mawa, PA | 3 |
| Ndibazza, J | 1 |
| Kizito, D | 2 |
| Namatovu, A | 1 |
| Kyosiimire-Lugemwa, J | 2 |
| Nanteza, B | 1 |
| Nampijja, M | 1 |
| Muhangi, L | 2 |
| Woodburn, PW | 1 |
| Akurut, H | 1 |
| Mpairwe, H | 1 |
| Akello, M | 1 |
| Lyadda, N | 1 |
| Bukusuba, J | 2 |
| Kihembo, M | 1 |
| Kizza, M | 3 |
| Kizindo, R | 1 |
| Nabulime, J | 1 |
| Ameke, C | 1 |
| Namujju, PB | 2 |
| Tweyongyere, R | 1 |
| Muwanga, M | 2 |
| Whitworth, JA | 4 |
| Leutscher, PD | 1 |
| Ndhlovu, PD | 1 |
| Nkurunziza, P | 1 |
| Lule, S | 1 |
| Kaleebu, P | 1 |
| Walson, J | 1 |
| Sangaré, L | 1 |
| Naulikha, J | 1 |
| Piper, B | 1 |
| Richardson, B | 1 |
| Otieno, PA | 1 |
| Mbogo, LW | 1 |
| Berkley, JA | 1 |
| John-Stewart, G | 1 |
| Mwanakasale, V | 1 |
| Vounatsou, P | 1 |
| Sukwa, TY | 1 |
| Ziba, M | 1 |
| Ernest, A | 1 |
| Tanner, M | 1 |
| Joseph, S | 2 |
| Jones, FM | 1 |
| Laidlaw, ME | 1 |
| Mohamed, G | 1 |
| Watera, C | 3 |
| Dunne, DW | 2 |
| Brown, M | 2 |
| Quigley, MA | 1 |
| Rowland, S | 1 |
| Hughes, P | 1 |
| Zinyama, R | 2 |
| Mudenge, B | 1 |
| Hosseinipour, MC | 1 |
| Napravnik, S | 1 |
| Joaki, G | 1 |
| Gama, S | 1 |
| Mbeye, N | 1 |
| Banda, B | 1 |
| Martinson, F | 1 |
| Hoffman, I | 1 |
| Cohen, MS | 1 |
| Carod-Artal, FJ | 1 |
| Smith, C | 1 |
| Smith, H | 1 |
| Seaton, RA | 1 |
| Fox, R | 1 |
| Lucey, DR | 1 |
| Maguire, JH | 1 |
| Boyer, AE | 1 |
| Strand, M | 1 |
| Nahlen, BL | 1 |
| Ouma, JH | 1 |
| Lawn, SD | 1 |
| Mwinzia, P | 1 |
| Andove, J | 1 |
| Folks, TM | 1 |
| Orago, AS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression[NCT00507221] | 948 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection[NCT00344279] | 1,000 participants (Anticipated) | Observational | 2005-08-08 | Completed | |||
| Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth[NCT00817713] | 295 participants (Actual) | Interventional | 2009-01-31 | Terminated (stopped due to Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.) | |||
| Randomized, Double Blind, Placebo Controlled Trial of Albendazole in Soil-Transmitted Helminth and HIV-1 co-Infected Kenyan Individuals to Determine the Effect of Such Treatment on HIV-1 Disease Progression and Genital Shedding.[NCT00130910] | 234 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for praziquantel and HIV Coinfection
| Article | Year |
|---|---|
Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review.
Topics: Adult; Animals; Endemic Diseases; HIV Infections; HIV-1; Humans; Male; Praziquantel; Risk Factors; S | 2015 |
A review of female genital schistosomiasis.
Topics: Africa; Animals; Anthelmintics; Disease Susceptibility; Female; HIV Infections; Humans; Praziquantel | 2012 |
Neurological complications of Schistosoma infection.
Topics: Africa; Animals; Brain Diseases; Comorbidity; Diagnosis, Differential; Glucocorticoids; HIV Infectio | 2008 |
Schistosomiasis.
Topics: Adult; Animals; Female; Hepatitis B; HIV Infections; Humans; Male; Neoplasms; Oxamniquine; Praziquan | 1993 |
8 trials available for praziquantel and HIV Coinfection
| Article | Year |
|---|---|
Correlates of prior HIV testing and schistosomiasis treatment: Baseline survey findings from the "creating demand for fishermen's schistosomiasis HIV services" (FISH) cluster-randomized trial in Mangochi, Malawi.
Topics: HIV Infections; HIV Testing; Humans; Malawi; Praziquantel; Schistosomiasis; Surveys and Questionnair | 2023 |
Combined effectiveness of anthelmintic chemotherapy and WASH among HIV-infected adults.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Chemoprevention; Cohort Studies; Female; Helminthiasi | 2018 |
Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways.
Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Cervix Uteri; Disease Susceptibility; F | 2019 |
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.
Topics: Adolescent; Adult; Cohort Studies; Cross-Sectional Studies; Cytokines; Female; HIV Infections; HIV-1 | 2008 |
Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Albendazole; Anthelmintics; Communicable Diseases; Dose-Response Relationship, Drug; Double-B | 2011 |
The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda.
Topics: Adult; Albendazole; Anthelmintics; Cohort Studies; Double-Blind Method; Female; Helminthiasis; HIV I | 2012 |
Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial.
Topics: Adult; Albendazole; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progression; Female; Helmi | 2012 |
Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load.
Topics: Adult; Anthelmintics; CD4 Lymphocyte Count; Drug Administration Schedule; Female; HIV Infections; HI | 2005 |
24 other studies available for praziquantel and HIV Coinfection
| Article | Year |
|---|---|
Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Helminth; Antigens, Helminth; Child; Chil | 2019 |
Female Genital Schistosomiasis.
Topics: Africa, Southern; Animals; Female; Genital Diseases, Female; HIV Infections; Humans; Life Cycle Stag | 2019 |
Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer.
Topics: Africa South of the Sahara; Anthelmintics; Anti-Retroviral Agents; Awareness; Female; Genital Diseas | 2020 |
Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
Topics: Adolescent; Animals; Anthelmintics; Child; Cross-Sectional Studies; Female; HIV Infections; Humans; | 2021 |
Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
Topics: Adolescent; Adult; Africa; Animals; Anthelmintics; Child; Child, Preschool; Female; Genital Diseases | 2019 |
Association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy.
Topics: Adult; Animals; Anthelmintics; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Feces; HIV Infect | 2013 |
Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
Topics: Adolescent; Adult; Africa; Animals; Anthelmintics; Cost-Benefit Analysis; Disease Transmission, Infe | 2013 |
Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.
Topics: Adolescent; Adult; Animals; Cervix Uteri; Cohort Studies; Endemic Diseases; Female; HIV Infections; | 2013 |
Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antigens, CD; Cytokines; Female; Flow Cytome | 2014 |
Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
Topics: Adolescent; Angola; Animals; Anthelmintics; Chemoprevention; Child; Coinfection; Female; HIV Infecti | 2014 |
Coinfection with
Topics: Adult; Animals; Anthelmintics; Anti-HIV Agents; Antiprotozoal Agents; Coinfection; Diarrhea; Giardia | 2017 |
Schistosomiasis in an HIV-positive patient presenting as an anal fissure and giant anal polyp.
Topics: Adult; Animals; Anthelmintics; Anus Diseases; Combined Modality Therapy; Diagnosis, Differential; Fe | 2008 |
Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.
Topics: Adult; Animals; Anthelmintics; Drug Resistance; HIV Infections; Humans; Liver Diseases, Parasitic; L | 2009 |
Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.
Topics: Adolescent; Adult; Animals; Anthelmintics; Chemokine CCL3; Cohort Studies; Female; Gene Expression R | 2009 |
Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
Topics: Adolescent; Adult; Animals; Anthelmintics; Child; Cohort Studies; Drug Administration Schedule; Fema | 2003 |
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
Topics: Adult; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Cytokines; HIV Infections; | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.
Topics: Adult; Anthelmintics; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; HIV Infections; Huma | 2005 |
Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.
Topics: Adult; Anthelmintics; Antigens, Helminth; CD4 Lymphocyte Count; Feces; Female; HIV Infections; Human | 2006 |
HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi.
Topics: Adult; Albendazole; Ambulatory Care; Anthelmintics; Antiprotozoal Agents; CD4 Lymphocyte Count; Fece | 2007 |
Seroprevalence of schistosomiasis in African patients infected with HIV.
Topics: Adult; Africa South of the Sahara; Animals; Enzyme-Linked Immunosorbent Assay; Feces; Female; HIV In | 2008 |
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Antiplatyhelmintic Agents; CD4 Lymphocyte Count; | 1998 |
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals.
Topics: Adult; Animals; Anthelmintics; Antigens, Helminth; Feces; HIV Infections; HIV-1; Humans; Male; Paras | 2000 |
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals.
Topics: Adult; Animals; Anthelmintics; Antigens, Helminth; Feces; HIV Infections; HIV-1; Humans; Male; Paras | 2000 |
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals.
Topics: Adult; Animals; Anthelmintics; Antigens, Helminth; Feces; HIV Infections; HIV-1; Humans; Male; Paras | 2000 |
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals.
Topics: Adult; Animals; Anthelmintics; Antigens, Helminth; Feces; HIV Infections; HIV-1; Humans; Male; Paras | 2000 |
Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.
Topics: Adolescent; Adult; Animals; Anthelmintics; CD4 Lymphocyte Count; Cells, Cultured; Cytokines; HIV Inf | 2001 |